Pharma Stock Roundup: Key Earnings Reports from Major Drugmakers
Nov 2, 2024
Pharmaceuticals Invest Information
SciSparc Granted FDA Approval for Phase IIb Trial of Novel Tourette Syndrome Therapy
Oct 1, 2024
Zydus Achieves USFDA Approval for Enzalutamide Capsules, Signalling Potential Market Movement
Sep 29, 2024
FDA Removes Clinical Hold on BMF-219 Trials for Diabetes by Biomea Fusion
Sep 27, 2024
AstraZeneca Pharma Gains CDSCO Approval for Durvalumab Importation
Sep 25, 2024
Dupixent Receives CHMP Endorsement for Pediatric Eosinophilic Esophagitis Treatment in the EU
Sep 21, 2024
argenx Highlights the Lancet Neurology Publication of Groundbreaking ADHERE Study Data for CIDP Treatment
Sep 20, 2024
Valneva Seeks to Extend IXCHIQ® Usage Through EMA and Health Canada Applications
Sep 18, 2024
Novartis's Kisqali Demonstrates a 28.5% Decrease in Recurrence Risk in Early Breast Cancer Patients
Sep 17, 2024
Dupixent® (dupilumab) Receives U.S. Approval for Treating Chronic Rhinosinusitis with Nasal Polyps in Adolescents
Sep 14, 2024
Emergent BioSolutions Secures $41.9 Million BARDA Option for Ebanga™ Ebola Treatment Development
Sep 13, 2024
Johnson & Johnson Targets FDA Approval for Groundbreaking gMG Drug Amidst Fierce Competition
Aug 30, 2024
Positive Topline Results for Novartis' Leqvio® in Lowering LDL-C in Low-to-Moderate ASCVD Risk Patients
Aug 28, 2024
Regeneron Showcases Respiratory Treatments at ERS 2024 Congress
Aug 26, 2024
Hims & Hers Health Soars Amid Demand for GLP-1 Weight Loss Alternatives
Aug 20, 2024
Certara Debuts Phoenix™ Version 8.5 Software to Advance Drug Development
Aug 16, 2024
Aarti Drugs' Baddi Unit Receives EIR from USFDA, Positive Signal for Investors
Jul 30, 2024
An Insight into Investment Trends: Trading Costs, Pharmaceuticals, and Alphabet Inc.
Jul 29, 2024
Addex Therapeutics Faces Setback as Partner Halts ADX71149 Development in Epilepsy
Jul 22, 2024
Investment Alert: Marinus Pharmaceuticals Investors Encouraged to Review Losses
Jul 14, 2024
FDA Grants Approval to Arcutis' Novel ZORYVE® Cream for Atopic Dermatitis Patients
Jul 10, 2024
Innovative COPD Therapy Dupixent Gains Approval in the EU, Marking a First for Targeted Treatment
Jul 4, 2024
Dr Reddy's Laboratories Share Price Rallies Following Nicotinell Acquisition Despite Brokerage Skepticism
Jun 27, 2024
WHO and Eli Lilly Warn Against Counterfeit Weight-Loss Medications
Jun 21, 2024
Glenmark Clinches USFDA Approval for Esomeprazole Magnesium Delayed-Release Capsules
Jun 13, 2024
Market Watch: Inflation Worries Trigger Stock Decline; Apple's AI Prospects Attract Investors
Jun 12, 2024
FDA Grants Accelerated Approval to Ipsen and Genfit's Iqirvo for Liver Disease Treatment
Jun 12, 2024
GENFIT Reaches Historic FDA Approval with Ipsen's Iqirvo® for Primary Biliary Cholangitis
Jun 11, 2024
Novartis Phase III Trial Shows Atrasentan Promising for IgA Nephropathy Treatment
May 26, 2024
Sobi's Emapalumab-lzsg Granted FDA Fast Track Designation for Macrophage Activation Syndrome
May 25, 2024
Sobi to Unveil Myelofibrosis Treatment Data at ASCO 2024
May 25, 2024
The Rising Trend of Weight-Loss Medications Among Youths: The Tale of Wegovy and its Impact
May 23, 2024
Inhibikase Therapeutics Sets Terms for Registered Direct Offering to Raise $4.0 Million
May 21, 2024
Sanofi’s Dupixent Under FDA Priority Review for Adolescents with CRSwNP
May 14, 2024
Recursion Pharmaceuticals Soars on Q1 Earnings Beat
May 10, 2024
NewAmsterdam Pharma Announces Upcoming R&D Day Featuring Key Opinion Leaders on May 16, 2024
May 2, 2024
Amylyx Pharmaceuticals (AMLX) Shares Plunge Following Phase 3 Setback and Legal Troubles
Mar 13, 2024
Arcutis Announces Key Roflumilast Cream Data for Young Children with Atopic Dermatitis
Mar 11, 2024
Quoin Pharmaceuticals Gains FDA Approval to Include Teens in Netherton Syndrome Studies, Boosting QNRX Shares
Mar 5, 2024
SpringWorks Therapeutics Begins Rolling NDA Submission for NF1-PN Treatment
Mar 5, 2024
SciSparc Advances Autism Spectrum Disorder Treatment with SCI-210 Clinical Trial Progression
Mar 1, 2024
Global Topical Antibiotics Market Set to Expand to USD 10.0 Billion by 2031, Progressing at 5.1% CAGR
Feb 21, 2024
FDA Approves Asthma Drug Xolair for Treating Severe Food Allergies
Feb 17, 2024
Class Action Suit Filed Against Amylyx Pharmaceuticals -- Investors Prompted to Seek Legal Counsel
Feb 11, 2024
Pharmaceutical Giants Defend Drug Pricing in Senate Hearing Amid Sanders' Critique
Feb 10, 2024
Agios Pharmaceuticals AGIO Braces for Potential Decline in Q4 Earnings
Feb 9, 2024
Inhibikase Therapeutics Provides Update on FDA Pre-NDA Meeting for Cancer Treatment
Feb 8, 2024
EMA Validates Marketing Application for Tisotumab Vedotin, A Potential Treatment for Recurrent or Metastatic Cervical Cancer
Feb 3, 2024
Novartis Scemblix® Outperforms Traditional TKIs in Phase III CML Trial
Jan 8, 2024
XORTX Advances Kidney Disease Treatment with a Novel Patent Submission
Jan 3, 2024
Eli Lilly Triumphs in Acquisition of POINT Biopharma, Enhancing Radiopharmaceutical Development
Dec 28, 2023
ReShape Lifesciences Soars on FDA Approval, Premarket Stock Movements Observed Across Various Sectors
Dec 14, 2023
Four High-Liquidity Stocks for Potentially Robust Returns: PBYI, GCT, AMPH, and DBX
Dec 11, 2023
LITFULO™ Wins Health Canada Nod as Novel Alopecia Areata Treatment
Dec 5, 2023
The Rise of Obesity-Fighting Drugs and Their Impact on Novo Nordisk
Dec 4, 2023
AstraZeneca AZN Cancels Two Key Phase III Trials for Hyperkalemia Drug Lokelma
Dec 2, 2023
Ramaswamy's Election Pledge to Lift Federal Bans on Cannabis and Psychedelics Sparks Interest in Pharma Sector
Nov 25, 2023
SciSparc Ltd. (NASDAQ:SPRC) Soars on Positive Clinical Trial Launch
Nov 25, 2023
Simcere Pharmaceuticals and Connect Biopharma Announce Collaboration on Innovative Autoimmune Drug
Nov 24, 2023
Nvidia Joins Forces with Alphabet Spinoff SandboxAQ on Drug Discovery and Material Innovation
Nov 21, 2023
Inhibikase Therapeutics Announces Q3 Financial Results and Activities Update
Nov 15, 2023
Actinium Pharmaceuticals Receives Sell Rating Upgrade Amid Market Movements
Nov 12, 2023
Wegovy Obesity Drug Shows 20% Reduction in Heart Problem Risk, Could Revolutionize Treatment
Nov 12, 2023
FDA Approves Ixchiq: First Vaccine for Chikungunya Virus by Valneva
Nov 10, 2023
Catalyst Pharmaceuticals Delivers Mixed Q3 Results While Raising 2023 Outlook
Nov 9, 2023